Viktor Kocka

Showing 1-3 of 3 articles

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Coronary interventions

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

Tousek P, Kocka V, Maly M, Kozel M, Petr R, Hajsl M, Jarkovsky J, Lisa L, Buděsinsky T, Widimsky P

May 16, 2016 | 10.4244/EIJV12I1A5

How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?

Martin-Yuste V, Alvarez-Contreras L, Sabaté M, Kelbæk H, Saunamäki K, Jørgensen E, Kocka V

February 20, 2015 | 10.4244/EIJV10I10A208

1

Latest news

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

NEW ahead of print: FFR and myocardial mass

Post atrioventricular (AV) branch intervention coronary angiogram

CTO Percutaneous Coronary Intervention Scores: Present and Future

Evangelia Vemmou

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Cardiocerebral Continuum in Cognitive Function After TAVI

This week’s JAA’s: Coronary Bifurcation in Asia Pacific, 3year outcomes: Compare-ACUTE...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke